Joo Han Lim Selected Research

pegylated granulocyte colony-stimulating factor

4/2016

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joo Han Lim Research Topics

Disease

18	Neoplasms (Cancer) 06/2023 - 10/2010
10	Pancreatic Neoplasms (Pancreatic Cancer) 06/2023 - 09/2012
6	Neoplasm Metastasis (Metastasis) 06/2023 - 09/2008
4	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 12/2008
3	Hypoxia (Hypoxemia) 03/2020 - 02/2012
3	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2012 - 04/2008
2	Brain Neoplasms (Brain Tumor) 07/2022 - 12/2013
2	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2016
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 01/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017 - 03/2016
2	Febrile Neutropenia 04/2016 - 09/2011
2	Neutropenia 04/2016 - 09/2011
2	Stomach Neoplasms (Stomach Cancer) 10/2010 - 09/2008
1	Adenocarcinoma 06/2023
1	Glioma (Gliomas) 07/2022
1	Nausea 07/2022
1	Thrombocytopenia (Thrombopenia) 07/2022
1	Vomiting 07/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Pain (Aches) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2020
1	Glioblastoma (Glioblastoma Multiforme) 03/2020
1	Rheumatoid Arthritis 03/2020
1	Cytokine Release Syndrome 01/2020
1	Pancreatitis 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2017
1	Inflammation (Inflammations) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 11/2016
1	Hemorrhagic Cystitis 04/2016
1	Aplastic Anemia (Anemia, Hypoplastic) 04/2016
1	Anorexia 04/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2016

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 06/2023 - 09/2012
4	ethyl 6- (5- (phenylsulfonamido)pyridin- 3- yl)imidazo(1,2- a)pyridine- 3- carboxylateIBA 01/2019 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2017 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 08/2014 - 10/2009
2	Fibronectins (Fibronectin)IBA 06/2023 - 01/2022
2	CollagenIBA 06/2023 - 01/2022
2	palbociclibIBA 01/2022 - 11/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 04/2012
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 02/2016
2	Rituximab (Mabthera)FDA Link 01/2017 - 03/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 04/2016
2	Docetaxel (Taxotere)FDA Link 04/2016 - 12/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2023
1	vactosertibIBA 06/2023
1	Phosphotransferases (Kinase)IBA 06/2023
1	Temozolomide (Temodar)FDA LinkGeneric 07/2022
1	Discoidin Domain Receptor 1IBA 01/2022
1	Anesthetics (Anesthetic Agents)IBA 01/2022
1	Local AnestheticsIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2022
1	VimentinIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Hormones (Hormone)IBA 01/2021
1	Guanosine Triphosphate (GTP)IBA 01/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	Cyclin D1IBA 11/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2020
1	Caspase 3 (Caspase-3)IBA 03/2020
1	Pulsatilla saponin DIBA 03/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2020
1	Anaphylatoxin C5a ReceptorIBA 01/2020
1	AngiopoietinsIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 12/2019
1	MelatoninIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 12/2017
1	DNA-Activated Protein KinaseIBA 12/2017
1	dactolisibIBA 10/2017
1	Oxygen (Dioxygen)IBA 10/2017
1	AlbuminsIBA 01/2017
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	R-CHOP protocolIBA 01/2017
1	Leflunomide (Arava)FDA LinkGeneric 04/2016
1	pegfilgrastim (Neulasta)FDA Link 04/2016
1	pegylated granulocyte colony-stimulating factorIBA 04/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2016

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 07/2022 - 09/2008
7	Therapeutics 07/2022 - 09/2011
3	Transplantation 04/2016 - 05/2009
2	Hematopoietic Stem Cell Transplantation 07/2010 - 04/2008
1	Immunotherapy 07/2022
1	Castration 01/2021
1	Radiotherapy 12/2017
1	Stem Cell Transplantation 04/2016
1	Subcutaneous Injections 04/2016
1	Splenectomy 02/2016